Updated Survival Analysis of the Randomized Phase III Trial of S-1 Versus Capecitabine in the First-Line Treatment of Metastatic Colorectal Cancer by the Dutch Colorectal Cancer Group

Johannes J M Kwakman; Erik van Werkhoven; Lieke H J Simkens; Johan M van Rooijen; Yes A J van de Wouw; Albert J Ten Tije; Geert-Jan M Creemers; Mathijs P Hendriks; Maartje Los; Robbert J van Alphen; Marco B Polée; Erik W Muller; Ankie M T van der Velden; Theo van Voorthuizen; Miriam Koopman; Linda Mol; Cornelis J A Punt

doi:10.1016/j.clcc.2019.01.002

Updated Survival Analysis of the Randomized Phase III Trial of S-1 Versus Capecitabine in the First-Line Treatment of Metastatic Colorectal Cancer by the Dutch Colorectal Cancer Group

Johannes J M Kwakman^*
, Erik van Werkhoven
, Lieke H J Simkens
, Johan M van Rooijen
, Yes A J van de Wouw
, Albert J Ten Tije
, Geert-Jan M Creemers
, Mathijs P Hendriks
, Maartje Los
, Robbert J van Alphen
, Marco B Polée
, Erik W Muller
, Ankie M T van der Velden
, Theo van Voorthuizen
, Miriam Koopman
, Linda Mol
, Cornelis J A Punt

^*Corresponding author for this work

Research output: Contribution to journal › Letter › Academic › peer-review

Original language	English
Pages (from-to)	e229-e230
Journal	Clinical colorectal cancer
Volume	18
Issue number	2
Early online date	29 Jan 2019
DOIs	https://doi.org/10.1016/j.clcc.2019.01.002
Publication status	Published - Jun 2019

Access to Document

10.1016/j.clcc.2019.01.002

kwakmanFinal published version, 123 KBLicence: Taverne

Cite this

Kwakman, J. J. M., van Werkhoven, E., Simkens, L. H. J., van Rooijen, J. M., van de Wouw, Y. A. J., Tije, A. J. T., Creemers, G.-J. M., Hendriks, M. P., Los, M., van Alphen, R. J., Polée, M. B., Muller, E. W., van der Velden, A. M. T., van Voorthuizen, T., Koopman, M., Mol, L., & Punt, C. J. A. (2019). Updated Survival Analysis of the Randomized Phase III Trial of S-1 Versus Capecitabine in the First-Line Treatment of Metastatic Colorectal Cancer by the Dutch Colorectal Cancer Group. Clinical colorectal cancer, 18(2), e229-e230. https://doi.org/10.1016/j.clcc.2019.01.002

@article{35a5b04c02bc49c99115e9d10727ccce,

title = "Updated Survival Analysis of the Randomized Phase III Trial of S-1 Versus Capecitabine in the First-Line Treatment of Metastatic Colorectal Cancer by the Dutch Colorectal Cancer Group",

author = "Kwakman, \{Johannes J M\} and \{van Werkhoven\}, Erik and Simkens, \{Lieke H J\} and \{van Rooijen\}, \{Johan M\} and \{van de Wouw\}, \{Yes A J\} and Tije, \{Albert J Ten\} and Creemers, \{Geert-Jan M\} and Hendriks, \{Mathijs P\} and Maartje Los and \{van Alphen\}, \{Robbert J\} and Pol{\'e}e, \{Marco B\} and Muller, \{Erik W\} and \{van der Velden\}, \{Ankie M T\} and \{van Voorthuizen\}, Theo and Miriam Koopman and Linda Mol and Punt, \{Cornelis J A\}",

year = "2019",

month = jun,

doi = "10.1016/j.clcc.2019.01.002",

language = "English",

volume = "18",

pages = "e229--e230",

journal = "Clinical colorectal cancer",

issn = "1533-0028",

publisher = "Elsevier",

number = "2",

}

Kwakman, JJM, van Werkhoven, E, Simkens, LHJ, van Rooijen, JM, van de Wouw, YAJ, Tije, AJT, Creemers, G-JM, Hendriks, MP, Los, M, van Alphen, RJ, Polée, MB, Muller, EW, van der Velden, AMT, van Voorthuizen, T, Koopman, M, Mol, L & Punt, CJA 2019, 'Updated Survival Analysis of the Randomized Phase III Trial of S-1 Versus Capecitabine in the First-Line Treatment of Metastatic Colorectal Cancer by the Dutch Colorectal Cancer Group', Clinical colorectal cancer, vol. 18, no. 2, pp. e229-e230. https://doi.org/10.1016/j.clcc.2019.01.002

Updated Survival Analysis of the Randomized Phase III Trial of S-1 Versus Capecitabine in the First-Line Treatment of Metastatic Colorectal Cancer by the Dutch Colorectal Cancer Group. / Kwakman, Johannes J M; van Werkhoven, Erik; Simkens, Lieke H J et al.
In: Clinical colorectal cancer, Vol. 18, No. 2, 06.2019, p. e229-e230.

Research output: Contribution to journal › Letter › Academic › peer-review

TY - JOUR

T1 - Updated Survival Analysis of the Randomized Phase III Trial of S-1 Versus Capecitabine in the First-Line Treatment of Metastatic Colorectal Cancer by the Dutch Colorectal Cancer Group

AU - Kwakman, Johannes J M

AU - van Werkhoven, Erik

AU - Simkens, Lieke H J

AU - van Rooijen, Johan M

AU - van de Wouw, Yes A J

AU - Tije, Albert J Ten

AU - Creemers, Geert-Jan M

AU - Hendriks, Mathijs P

AU - Los, Maartje

AU - van Alphen, Robbert J

AU - Polée, Marco B

AU - Muller, Erik W

AU - van der Velden, Ankie M T

AU - van Voorthuizen, Theo

AU - Koopman, Miriam

AU - Mol, Linda

AU - Punt, Cornelis J A

PY - 2019/6

Y1 - 2019/6

UR - https://www.scopus.com/pages/publications/85066491401

U2 - 10.1016/j.clcc.2019.01.002

DO - 10.1016/j.clcc.2019.01.002

M3 - Letter

C2 - 30782413

SN - 1533-0028

VL - 18

SP - e229-e230

JO - Clinical colorectal cancer

JF - Clinical colorectal cancer

IS - 2

ER -

Kwakman JJM, van Werkhoven E, Simkens LHJ, van Rooijen JM, van de Wouw YAJ, Tije AJT et al. Updated Survival Analysis of the Randomized Phase III Trial of S-1 Versus Capecitabine in the First-Line Treatment of Metastatic Colorectal Cancer by the Dutch Colorectal Cancer Group. Clinical colorectal cancer. 2019 Jun;18(2):e229-e230. Epub 2019 Jan 29. doi: 10.1016/j.clcc.2019.01.002

Updated Survival Analysis of the Randomized Phase III Trial of S-1 Versus Capecitabine in the First-Line Treatment of Metastatic Colorectal Cancer by the Dutch Colorectal Cancer Group

Access to Document

Other files and links

Cite this